![David Kelly](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David Kelly is currently the Chief Financial Officer at ArraVasc Ltd. Prior to this, he worked as a Principal at Boston Scientific Corp., Aryzta AG, and Chanelle Pharmaceuticals Manufacturing Ltd. He also served as the Chief Financial Officer & Treasurer at Cappella, Inc.
| Företag | Position | Slut |
|---|---|---|
ArraVasc Ltd.
 ArraVasc Ltd. Medical SpecialtiesHealth Technology Develops novel solutions for the treatment of complex coronary artery disease | Finansdirektör/CFO | 2021-08-31 |
| ARYZTA AG | Företagsledare/Principal | - |
Chanelle Pharmaceuticals Manufacturing Ltd.
 Chanelle Pharmaceuticals Manufacturing Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and markets generic animal pharmaceutical products | Företagsledare/Principal | - |
| BOSTON SCIENTIFIC CORPORATION | Företagsledare/Principal | - |
Cappella, Inc.
 Cappella, Inc. Pharmaceuticals: MajorHealth Technology Operates as a medical device company | Finansdirektör/CFO | - |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
| Privata företag | 5 |
|---|---|
Boston Scientific Corp.
 Boston Scientific Corp. Medical SpecialtiesHealth Technology Develops, manufactures and markets cardiology, endoscopy, peripheral intervention, urology & neuromodulation equipment | Health Technology |
Cappella, Inc.
Cappella, Inc. Pharmaceuticals: MajorHealth Technology Operates as a medical device company | Health Technology |
Aryzta AG
 Aryzta AG Food RetailRetail Trade Produces frozen baked goods | Retail Trade |
Chanelle Pharmaceuticals Manufacturing Ltd.
Chanelle Pharmaceuticals Manufacturing Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and markets generic animal pharmaceutical products | Health Technology |
ArraVasc Ltd.
ArraVasc Ltd. Medical SpecialtiesHealth Technology Develops novel solutions for the treatment of complex coronary artery disease | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån
